| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |